[NBu4]2[Pt2(µ-PPh2)2(C6F5)4] reacts with cis-[Pt(C6F5)2(thf)2](1:2 molar ratio) yielding [NBu4][Pt3(µ-PPh2)2(C6F5)5] which contains unusual µ3-PPh(1,2-η2-Ph)-κ3P phosphido and semi-bridging C6F5 ligands and two Pt–Pt bonds of length 2.899(1) and 2.772(1)Å.
No takes yet. Share an insight, caveat, or question.
Alonso et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: